METRICS INC. SUSTAINS GROWTH MOMENTUM IN FIRST HALF OF YEAR
GREENVILLE, N.C. – Metrics, Inc., a full–service pharmaceutical development contract research organization, announced that its revenue growth continued on pace with the 20–percent growth experienced in 2006.
In addition, Metrics continues to expand its workforce and is simultaneously doubling the size of its current facility, which should be occupied in the fourth quarter of this year.
Metrics‘ chief executive officer attributed the company‘s continued growth to its ”speed to clinical trials“ for studies being conducted in human subjects for the first time.
“The new molecular entity contract development services provided by Metrics is a favorite among our clients,” said Phil Hodges, CEO. “Clients appreciate our ability to meet critical deadlines for such first-time-in-man studies.”
Metrics, headquartered in Greenville, N.C., is one of the fastest-growing contract pharmaceutical development laboratories in the United States. The company provides quality formulation, clinical trial manufacturing and analytical development/validation services to the pharmaceutical industry.
In September, Metrics announced a $17.5-million facility expansion. The 47,000–square–foot facility will allow the company to hire 50 new employees and dramatically augment its clinical batch manufacturing and commercial production capabilities in the next three years. For more information about Metrics and its services, visit its Web site at www.metricsinc.com
Contact: Jeffery C Basham, VP Marketing & Sales, 252.317.3880
